Reviews the basic science of the DDR, its role in tumorigenesis, in dictating response to DNA damaging drugs and the emerging crop of clinical agents that target the DDR for potential anti-cancer benefitIt features chapters from world leaders in the field of DNA Damage Response and covers topics that are of great interest to a broad range of academic, industrial and clinical researchers